{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:41:19Z","timestamp":1794480079087,"version":"4.9.1"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T00:00:00Z","timestamp":1570406400000},"content-version":"vor","delay-in-days":67,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013996","name":"The Global Health Innovative Technology Fund","doi-asserted-by":"crossref","award":["G2018\u2013111"],"award-info":[{"award-number":["G2018\u2013111"]}],"id":[{"id":"10.13039\/501100013996","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004419","name":"CRDF Global","doi-asserted-by":"publisher","award":["62966"],"award-info":[{"award-number":["62966"]}],"id":[{"id":"10.13039\/100004419","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI025038"],"award-info":[{"award-number":["R01AI025038"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["631"],"award-info":[{"award-number":["631"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["39129"],"award-info":[{"award-number":["39129"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","award":["11921"],"award-info":[{"award-number":["11921"]}],"id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"name":"EDCTP-TDR Clinical Research Development Fellowship 2018"},{"DOI":"10.13039\/501100001691","name":"Japanese Society for the Promotion of Science","doi-asserted-by":"crossref","award":["18H02649"],"award-info":[{"award-number":["18H02649"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:p>Visceral leishmaniasis (VL) in the Old World is caused by infection with Leishmania donovani. Although the numbers of new reported cases of VL in Africa have been relatively stable for several years, the low numbers currently reported on the Indian subcontinent suggest a positive impact of new treatments and intervention strategies. In both regions, however, VL relapse and post-kala-azar dermal leishmaniasis (PKDL) maintain infectious reservoirs and therefore present a threat to control programs. In this review, we outline the evolving appreciation of PKDL as an impactful disease in its own right and discuss the various diagnostic methods that can be applied for the detection and characterization of PKDL cases. We also highlight the data that indicate the potential, and likely contribution, of PKDL cases to ongoing transmission of L. donovani.<\/jats:p>","DOI":"10.1093\/femspd\/ftz057","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T03:23:56Z","timestamp":1570159436000},"source":"Crossref","is-referenced-by-count":14,"title":["Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of <i>Leishmania donovani<\/i>"],"prefix":"10.1093","volume":"77","author":[{"given":"Malcolm S","family":"Duthie","sequence":"first","affiliation":[{"name":"Infectious Disease Research Institute, 1616 Eastlake Ave E, Suite 400, Seattle, WA 98102, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Animal Resource Sciences, Graduate School of Agricultural and Life Sciences, University of Tokyo, 1-1-1 Yayoi, Bungkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Ghosh","sequence":"additional","affiliation":[{"name":"68 Shaheed Tajuddin Ahmed Saranai, Mokakhali, Dhaka-1212, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Mondal","sequence":"additional","affiliation":[{"name":"68 Shaheed Tajuddin Ahmed Saranai, Mokakhali, Dhaka-1212, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,7]]},"reference":[{"key":"2021052207401793500_bib1","doi-asserted-by":"crossref","first-page":"150746","DOI":"10.1155\/2013\/150746","article-title":"Systematic review into diagnostics for post-kala-azar dermal leishmaniasis (PKDL)","volume":"2013","author":"Adams","year":"2013","journal-title":"J Trop Med"},{"key":"2021052207401793500_bib2","first-page":"341","article-title":"Ten years of kala-azar in West Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?","volume":"70","author":"Addy","year":"1992","journal-title":"Bull World Health Organ"},{"key":"2021052207401793500_bib3","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1086\/518167","article-title":"Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature","volume":"44","author":"Antinori","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2021052207401793500_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1517\/14728214.2012.748036","article-title":"Liposomal amphotericin B as a treatment for human leishmaniasis","volume":"17","author":"Balasegaram","year":"2012","journal-title":"Expert Opin Emerg Drugs"},{"key":"2021052207401793500_bib5","doi-asserted-by":"crossref","first-page":"e3273","DOI":"10.1371\/journal.pntd.0003273","article-title":"IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test","volume":"8","author":"Bhattacharyya","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib6","doi-asserted-by":"crossref","first-page":"e2603","DOI":"10.1371\/journal.pntd.0002603","article-title":"Five-year field results and long-term effectiveness of 20\u00a0mg\/kg liposomal amphotericin B (AmBisome) for visceral leishmaniasis in Bihar, India","volume":"8","author":"Burza","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.38917.503056.7C","article-title":"A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis","volume":"333","author":"Chappuis","year":"2006","journal-title":"BMJ"},{"key":"2021052207401793500_bib8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"2021052207401793500_bib10","first-page":"141","article-title":"Development of the parasite of Indian kala-azar in the sandfly Phlebotomus argentipes: refed flies and further results of the feeding of sandflies on kala-azar cases","volume":"4","author":"Christophers","year":"1926","journal-title":"Indian Med Res Memoirs"},{"key":"2021052207401793500_bib9","first-page":"605","article-title":"The development of the parasite of Indian kala-azar in the sandfly Phlebotomus argentipes Annandale and Brunetti","volume":"12","author":"Christophers","year":"1924","journal-title":"Indian J Med Res"},{"key":"2021052207401793500_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-4632.2010.04558.x","article-title":"Post-kala-azar dermal leishmaniasis\u2014an overview","volume":"49","author":"Ganguly","year":"2010","journal-title":"Int J Dermatol"},{"key":"2021052207401793500_bib12","doi-asserted-by":"crossref","first-page":"e0004138","DOI":"10.1371\/journal.pntd.0004138","article-title":"PKDL\u2013A silent parasite pool for transmission of leishmaniasis in kala-azar endemic areas of Malda district, West Bengal, India","volume":"9","author":"Ganguly","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib13","doi-asserted-by":"crossref","first-page":"e0203407","DOI":"10.1371\/journal.pone.0203407","article-title":"Knowledge, stigma, health seeking behaviour and its determinants among patients with post kala-azar dermal leishmaniasis, Bihar, India","volume":"13","author":"Garapati","year":"2018","journal-title":"PLoS One"},{"key":"2021052207401793500_bib14","doi-asserted-by":"crossref","first-page":"ofy234","DOI":"10.1093\/ofid\/ofy234","article-title":"Evaluation of real-time PCR for diagnosis of post-kala-azar dermal leishmaniasis in endemic foci of Bangladesh","volume":"5","author":"Ghosh","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2021052207401793500_bib15","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","article-title":"Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial","volume":"4","author":"Hailu","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib16","doi-asserted-by":"crossref","first-page":"e0185606","DOI":"10.1371\/journal.pone.0185606","article-title":"Real-time PCR in detection and quantitation of Leishmania donovanifor the diagnosis of visceral leishmaniasis patients and the monitoring of their response to treatment","volume":"12","author":"Hossain","year":"2017","journal-title":"PLoS One"},{"key":"2021052207401793500_bib17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4269\/ajtmh.12-0711","article-title":"Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh","volume":"89","author":"Islam","year":"2013","journal-title":"Am J Trop Med Hyg"},{"key":"2021052207401793500_bib18","doi-asserted-by":"crossref","first-page":"e0192302","DOI":"10.1371\/journal.pone.0192302","article-title":"Glycoproteins in circulating immune complexes are biomarkers of patients with Indian PKDL: a study from endemic districts of West Bengal, India","volume":"13","author":"Jaiswal","year":"2018","journal-title":"PLoS One"},{"key":"2021052207401793500_bib19","doi-asserted-by":"crossref","first-page":"e2613","DOI":"10.1371\/journal.pntd.0002613","article-title":"Safety and efficacy of single dose versus multiple doses of AmBisome for treatment of visceral leishmaniasis in eastern Africa: a randomised trial","volume":"8","author":"Khalil","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib20","first-page":"593","article-title":"On a herpetomonas found in the gut of the sandfly, Phlebotomus argentipes, fed on kala-azar patients","volume":"59","author":"Knowles","year":"1924","journal-title":"Indian Medical Gazette"},{"key":"2021052207401793500_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fcimb.2018.00427","article-title":"Visceral leishmaniasis IgG1 rapid monitoring of cure vs. relapse, and potential for diagnosis of post kala-azar dermal leishmaniasis","volume":"8","author":"Marlais","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"2021052207401793500_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/cid\/cix245","article-title":"Infectivity of post-kala-azar dermal leishmaniasis patients to sand flies: revisiting a proof of concept in the context of the kala-azar elimination program in the Indian Subcontinent","volume":"65","author":"Molina","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2021052207401793500_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/cid\/ciy891","article-title":"Quantifying the infectiousness of post-kala-azar dermal leishmaniasis towards sandflies","volume":"69","author":"Mondal","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021052207401793500_bib24","doi-asserted-by":"crossref","first-page":"e832","DOI":"10.1371\/journal.pntd.0000832","article-title":"Enhanced case detection and improved diagnosis of PKDL in a kala-azar-endemic area of Bangladesh","volume":"4","author":"Mondal","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pt.2013.12.004","article-title":"Post kala-azar dermal leishmaniasis: an unresolved mystery","volume":"30","author":"Mukhopadhyay","year":"2014","journal-title":"Trends Parasitol"},{"key":"2021052207401793500_bib26","first-page":"173","article-title":"The infection of Phlebotomus argentipes from dermal leishmanial lesions","volume":"21","author":"Napier","year":"1933","journal-title":"Indian J Med Res"},{"key":"2021052207401793500_bib27","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1128\/JCM.36.6.1621-1624.1998","article-title":"Use of PCR for diagnosis of post-kala-azar dermal leishmaniasis","volume":"36","author":"Osman","year":"1998","journal-title":"J Clin Microbiol"},{"key":"2021052207401793500_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12955-017-0720-y","article-title":"Assessment of quality of life in patients with post kalaazar dermal leishmaniasis","volume":"15","author":"Pal","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"2021052207401793500_bib29","doi-asserted-by":"crossref","first-page":"e0007173","DOI":"10.1371\/journal.pntd.0007173","article-title":"The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia\u2014a review and meta-analysis","volume":"13","author":"Pijpers","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-3305-5-15","article-title":"SYBR Green-based real-time PCR targeting kinetoplast DNA can be used to discriminate between the main etiologic agents of Brazilian cutaneous and visceral leishmaniases","volume":"5","author":"Pita-Pereira","year":"2012","journal-title":"Parasit Vectors"},{"key":"2021052207401793500_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1086\/648727","article-title":"Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh","volume":"50","author":"Rahman","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2021052207401793500_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-4362.1995.tb03584.x","article-title":"Post-kala-azar dermal leishmaniasis","volume":"34","author":"Ramesh","year":"1995","journal-title":"Int J Dermatol"},{"key":"2021052207401793500_bib33","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2021052207401793500_bib34","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.actatropica.2009.09.005","article-title":"PCR for diagnosis and assessment of cure in kala-azar patients in Bangladesh","volume":"113","author":"Salam","year":"2010","journal-title":"Acta Trop"},{"key":"2021052207401793500_bib35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/JCM.39.3.849-854.2001","article-title":"Development of a species-specific PCR assay for detection of Leishmania donovani in clinical samples from patients with kala-azar and post-kala-azar dermal leishmaniasis","volume":"39","author":"Salotra","year":"2001","journal-title":"J Clin Microbiol"},{"key":"2021052207401793500_bib36","doi-asserted-by":"crossref","first-page":"e0007249","DOI":"10.1371\/journal.pntd.0007249","article-title":"Active surveillance identified a neglected burden of macular cases of post kala-azar dermal leishmaniasis in West Bengal","volume":"13","author":"Sengupta","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib37","first-page":"589","article-title":"Transmission experiments in India kala-azar with Phlebotomus argentipes","volume":"14","author":"Shortt","year":"1926","journal-title":"Indian J Med Res"},{"key":"2021052207401793500_bib38","first-page":"239","article-title":"Note on dermal leishmanoid","volume":"16","author":"Shortt","year":"1928","journal-title":"Indian J Med Res"},{"key":"2021052207401793500_bib39","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1128\/JCM.42.4.1777-1778.2004","article-title":"Nested PCR assay for detection of Leishmania donovani in slit aspirates from post-kala-azar dermal leishmaniasis lesions","volume":"42","author":"Sreenivas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"2021052207401793500_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13071-017-1969-z","article-title":"Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India","volume":"10","author":"Srivastava","year":"2017","journal-title":"Parasit Vectors"},{"key":"2021052207401793500_bib41","doi-asserted-by":"crossref","first-page":"e3366","DOI":"10.1371\/journal.pntd.0003366","article-title":"Quantitative PCR in epidemiology for early detection of visceral leishmaniasis cases in India","volume":"8","author":"Sudarshan","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib43","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1056\/NEJMoa066536","article-title":"Injectable paromomycin for visceral leishmaniasis in India","volume":"356","author":"Sundar","year":"2007","journal-title":"N Engl J Med"},{"key":"2021052207401793500_bib42","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJMoa021556","article-title":"Oral miltefosine for Indian visceral leishmaniasis","volume":"347","author":"Sundar","year":"2002","journal-title":"N Engl J Med"},{"key":"2021052207401793500_bib44","first-page":"394","article-title":"Availability of miltefosine for the treatment of kala-azar in India","volume":"83","author":"Sundar","year":"2005","journal-title":"Bull World Health Organ"},{"key":"2021052207401793500_bib45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2021052207401793500_bib46","doi-asserted-by":"crossref","first-page":"e000709","DOI":"10.1136\/bmjgh-2018-000709","article-title":"Why miltefosine\u2014a life-saving drug for leishmaniasis\u2014is unavailable to people who need it the most","volume":"3","author":"Sunyoto","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2021052207401793500_bib47","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.4269\/ajtmh.17-0749","article-title":"Noninvasive sweat-based diagnosis of visceral leishmaniasis and post kala-azar dermal leishmaniasis","volume":"99","author":"Topno","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2021052207401793500_bib48","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10096-014-2282-9","article-title":"Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis","volume":"34","author":"Vallur","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021052207401793500_bib49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12879-015-1125-3","article-title":"Development and comparative evaluation of two antigen detection tests for visceral leishmaniasis","volume":"15","author":"Vallur","year":"2015","journal-title":"BMC Infect Dis"},{"key":"2021052207401793500_bib50","first-page":"474","article-title":"Quality of life in patients with cutaneous leishmaniasis","volume":"16","author":"Vares","year":"2013","journal-title":"Arch Iran Med"},{"key":"2021052207401793500_bib52","doi-asserted-by":"crossref","first-page":"e10107","DOI":"10.1371\/journal.pone.0010107","article-title":"Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis","volume":"5","author":"Verma","year":"2010","journal-title":"PLoS One"},{"key":"2021052207401793500_bib51","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1128\/JCM.01482-13","article-title":"Comparative evaluation of PCR and imprint smear microscopy analyses of skin biopsy specimens in diagnosis of macular, papular, and mixed papulo-nodular lesions of post-kala-azar dermal leishmaniasis","volume":"51","author":"Verma","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2021052207401793500_bib53","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1128\/JCM.r00764-11","article-title":"Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples","volume":"49","author":"Weirather","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2021052207401793500_bib54","volume-title":"Regional Strategic Framework for Elimination of Kala-azar from South East Asian Region (2005\u20132015)","author":"WHO","year":"2005"},{"key":"2021052207401793500_bib55","first-page":"557","article-title":"Global leishmaniasis update, 2006\u20132015: a turning point in leishmaniasis surveillance","volume":"92","author":"WHO","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"2021052207401793500_bib56","doi-asserted-by":"crossref","first-page":"999","DOI":"10.4269\/ajtmh.2005.73.999","article-title":"Rapid identification of leishmania complexes by a real-time PCR assay","volume":"73","author":"Wortmann","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"2021052207401793500_bib57","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1186\/s12879-018-3420-2","article-title":"Development of a sandwich ELISA to detect leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Infect Dis"},{"key":"2021052207401793500_bib58","doi-asserted-by":"crossref","first-page":"e0005877","DOI":"10.1371\/journal.pntd.0005877","article-title":"Post-kala-azar dermal leishmaniasis in the Indian subcontinent: a threat to the South-East Asia region kala-azar elimination programme","volume":"11","author":"Zijlstra","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2021052207401793500_bib59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","article-title":"Post-kala-azar dermal leishmaniasis","volume":"3","author":"Zijlstra","year":"2003","journal-title":"Lancet Infect Dis"}],"container-title":["Pathogens and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/femspd\/advance-article-pdf\/doi\/10.1093\/femspd\/ftz057\/30111467\/ftz057.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/77\/6\/ftz057\/38098861\/ftz057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/femspd\/article-pdf\/77\/6\/ftz057\/38098861\/ftz057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T07:41:36Z","timestamp":1621669296000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/femspd\/article\/doi\/10.1093\/femspd\/ftz057\/5582598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,1]]},"references-count":59,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/femspd\/ftz057","relation":{},"ISSN":["2049-632X"],"issn-type":[{"value":"2049-632X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,8,1]]},"article-number":"ftz057"}}